首页> 外文OA文献 >Efficacy of Anti-RON Antibody Zt/g4–Drug Maytansinoid Conjugation (Anti-RON ADC) as a Novel Therapeutics for Targeted Colorectal Cancer Therapy

【2h】

Efficacy of Anti-RON Antibody Zt/g4–Drug Maytansinoid Conjugation (Anti-RON ADC) as a Novel Therapeutics for Targeted Colorectal Cancer Therapy

机译：抗RON抗体ZT / G4-药物美洲素甾体类化合物缀合（抗RON ADC）作为针对靶向结直肠癌治疗的新疗效的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Liang Feng; Hang-Ping Yao; Wei Wang; Yong-Qing Zhou; Jianwei Zhou; Ruiwen Zhang; Ming-Hai Wang;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of Anti-RON Antibody Zt/g4-Drug Maytansinoid Conjugation (Anti-RON ADC) as a Novel Therapeutics for Targeted Colorectal Cancer Therapy [J] . Feng Liang, Yao Hang-Ping, Wang Wei, Clinical cancer research: an official journal of the American Association for Cancer Research . 2014,第23期

机译：抗RON抗体Zt / g4-药物美登木素生物碱共轭（抗RON ADC）作为靶向大肠癌治疗的新型疗法的功效
2. Preclinical Efficacy of Anti-RON Antibody Drug-Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase [J] . Yao Hang-Ping, Feng Liang, Weng Tian-Hao, Molecular pharmaceutics . 2018,第8期

机译：抗RON抗体药物 - 缀合物ZT / G4-MMAE用于靶向治疗胰腺癌过表达RON受体酪氨酸激酶的临床疗效
3. RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE [J] . Suthe Sreedhar Reddy, Yao Hang-Ping, Weng Tian-Hao, Molecular cancer therapeutics . 2018,第12期

机译：Ron受体酪氨酸激酶作为消除三阴性乳腺癌的治疗靶标：抗RON ADC ZT / G4-MMAE的功效
4. Drugs to Enhance the Therapeutic Potency of Anticancer Antibodies: Antibody-Drug Conjugates as Tumor-Activated Prodrugs [C] . Walter A. Blattler, Ravi V. J. Chari American Chemical Society . 2001

机译：药物以增强抗癌抗体治疗效力：抗体 - 药物缀合物作为肿瘤活化前药
5. Therapeutic Targeting of Chemotherapy-Resistant Colorectal Cancer Stem Cells with P73- and Trail-Based Small Molecules [D] . Prabhu, Varun Vijay. 2016

机译：基于P73和基于轨迹的小分子对化疗耐药的结直肠癌干细胞的治疗靶向
6. Therapeutic efficacy pharmacokinetic profiles and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy [O] . Hang-Ping Yao, Liang Feng, Sreedhar Reddy Suthe, 2019

机译：靶向RON受体酪氨酸激酶的人源化抗体-药物偶联物Zt / g4-MMAE的治疗功效药代动力学特征和毒理活性
7. Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy [O] . Hang-Ping Yao, Liang Feng, Sreedhar Reddy Suthe, 2019

机译：矫正：治疗疗效，药代动力学谱和人源化抗体 - 药物缀合物ZT / G4-MMAE靶向RON受体酪氨酸激酶的癌症治疗的毒理学活动

Efficacy of Anti-RON Antibody Zt/g4–Drug Maytansinoid Conjugation (Anti-RON ADC) as a Novel Therapeutics for Targeted Colorectal Cancer Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅